LIFE Current Ratio

The Current Ratio of Ethos Technologies Inc (LIFE) is 2.18.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

LIFE Current Ratio - Historical Value

Date	Value
2025-12-31	2.18
2024-12-31	2.57

LIFE Current Ratio - Peers Comparison

Ticker	Name	Value
BCDA	BioCardia Inc	1.12
BPTH	Bio Path Holdings Inc	1.60
CRYO	American Cryostem Corp	0.12
GNBT	Generex Biotechnology Corp	0.03
MRNA	Moderna Inc	3.29
BNTC	Benitec Biopharma Inc	10.57
BRTX	BioRestorative Therapies Inc	0.84
ENZN	Enzon Pharmaceuticals Inc	58.57
LIXT	Lixte Biotechnology Holdings Inc	3.60
INTI	Inhibitor Therapeutics Inc	3.19
NAVB	Navidea Biopharmaceuticals Inc	0.32
NNVC	NanoViricides, Inc	1.28
ABBV	AbbVie Inc	0.67
KTRA	Kintara Therapeutics Inc	2.45
NPHC	Nutra Pharma Corp	0.03
VIRI	Virios Therapeutics Inc	11.62
950160.KQ	Kolon TissueGene Inc	0.10
AMGN	Amgen Inc	1.14
GOVX	GeoVax Labs Inc	2.55
PMN.TO	ProMIS Neurosciences Inc	1.08
REGN	Regeneron Pharmaceuticals Inc	4.13
VRTX	Vertex Pharmaceuticals Inc	2.90
ADTX	Aditxt Inc	0.09
ARDS	Aridis Pharmaceuticals Inc	0.32
IKT	Inhibikase Therapeutics Inc	21.70
TENX	Tenax Therapeutics Inc	14.56
WINT	Windtree Therapeutics Inc	0.45
950200.KQ	Psomagen Inc	1.62
950220.KQ	Neoimmunetech Inc	1.89
GILD	Gilead Sciences Inc	1.55
IDRA	Idera Pharmaceuticals Inc	7.00
PKTX	ProtoKinetix Inc	-0.03
PTIX	Protagenic Therapeutics Inc	0.02
SKYE	Skye Bioscience Inc	3.30
YTEN	Yield10 Bioscience Inc	0.29